Chronic Kidney Disease Trial, Recruiting (NCT06374537)

Chronic Kidney Disease Trial, Recruiting NCT06374537 Sponsor: University of Illinois at Chicago Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06374537 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are seriously unwell due to kidney disease and are currently on dialysis, have stage 4 chronic kidney disease (meaning the kidneys are working at 15–29% of normal function), have stage 5 chronic kidney disease (meaning the kidneys are working at less than 15% of normal function), or have received a kidney transplant (for a specific subgroup of the trial only) — as confirmed by their healthcare professional.
People who have enough mental clarity to complete questionnaires, agree to take part in the study, and follow the physical activity and dietary instructions involved.

Who may not be able to join:

People with heart or lung conditions that make physical exercise unsafe or medically inadvisable.
People who are not able to give their own consent to participate in the trial.
People who are not able to travel to the training centre where the trial takes place.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enrico Benedetti, University of Illinois at Chicago

Phone: 312-996-9594

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06374537

Sponsor: University of Illinois at Chicago

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 312-996-9594

More information: https://clinicaltrials.gov/study/NCT06374537

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are seriously unwell due to kidney disease and are currently on dialysis, have stage 4 chronic kidney disease (meaning the kidneys are working at 15–29% of normal function), have stage 5 chronic kidney disease (meaning the kidneys are working at less than 15% of normal function), or have received a kidney transplant (for a specific subgroup of the trial only) — as confirmed by their healthcare professional.
People who have enough mental clarity to complete questionnaires, agree to take part in the study, and follow the physical activity and dietary instructions involved.

Who may not be able to join:

People with heart or lung conditions that make physical exercise unsafe or medically inadvisable.
People who are not able to give their own consent to participate in the trial.
People who are not able to travel to the training centre where the trial takes place.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Illinois at Chicago

Registry

ClinicalTrials.gov

Start date

22 May 2019

Est. completion

22 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate at which subjects will see changes in their physical abilities.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov